English español
Search
 

Repositorio de la Universidad de Oviedo. > Producción Bibliográfica de UniOvi: RECOPILA > Artículos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10651/51392

Title: Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome
Author(s): Santiago Fernández, Olaya
García Osorio, Fernando
Quesada Fernández, Víctor
Rodríguez, Francisco
Basso, Sammy
Maeso, Daniel
Rolas, Loïc
Barkaway, Anna
Nourshargh, Sussan
Rodríguez Folgueras, Alicia
Pérez Freije, José María
López Otín, Carlos
Issue date: 2019
Publisher version: https://doi.org/10.1038/s41591-018-0338-6
Citation: Nature medicine, 25, p. 423–426 (2019); doi:10.1038/s41591-018-0338-6
Format extent: p. 423–426
URI: http://hdl.handle.net/10651/51392
ISSN: 1078-8956
Sponsored: The Instituto Universitario de Oncología del Principado de Asturias is supported by Fundación Bancaria Caja de Ahorros de Asturias. J.M.P.F. is supported by Ministerio de Economía y Competitividad (MINECO/FEDER: No. SAF2015-64157-R) and Gobierno del Principado de Asturias. C.L.-O. is supported by grants from the European Research Council (ERC-2016-ADG, DeAge), Ministerio de Economía y Competitividad (MINECO/FEDER: Nos. SAF2014-52413-R and SAF2017-87655-R), Instituto de Salud Carlos III (RTICC) and Progeria Research Foundation (No. PRF2016-66). O.S.-F. is recipient of an FPU fellowship. A.R.F. is recipient of a Ramón y Cajal fellowship. The generation of progerin antibody was funded by the Wellcome Trust (No. 098291/Z/12/Z to S.N.).
Project id.: ERC-2016-ADG
MINECO/FEDER/SAF2014-52413-R
MINECO/FEDER/SAF2017-87655-R
Appears in Collections:Bioquímica y Biología Molecular
Artículos
Investigaciones y Documentos OpenAIRE

Files in This Item:

File Description SizeFormat
Development.pdfPostprint3,96 MBAdobe PDFView/Open


Exportar a Mendeley


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Base de Datos de Autoridades Biblioteca Universitaria Consultas / Sugerencias